207 related articles for article (PubMed ID: 15228255)
21. Principal role of dihydropteroate synthase mutations in mediating resistance to sulfadoxine-pyrimethamine in single-drug and combination therapy of uncomplicated malaria in Uganda.
Dorsey G; Dokomajilar C; Kiggundu M; Staedke SG; Kamya MR; Rosenthal PJ
Am J Trop Med Hyg; 2004 Dec; 71(6):758-63. PubMed ID: 15642967
[TBL] [Abstract][Full Text] [Related]
22. The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics.
A-Elbasit IE; Alifrangis M; Khalil IF; Bygbjerg IC; Masuadi EM; Elbashir MI; Giha HA
Malar J; 2007 Aug; 6():108. PubMed ID: 17686173
[TBL] [Abstract][Full Text] [Related]
23. Ordered accumulation of mutations conferring resistance to sulfadoxine-pyrimethamine in the Plasmodium falciparum parasite.
Mita T; Ohashi J; Venkatesan M; Marma AS; Nakamura M; Plowe CV; Tanabe K
J Infect Dis; 2014 Jan; 209(1):130-9. PubMed ID: 23922363
[TBL] [Abstract][Full Text] [Related]
24. Plasmodium falciparum drug resistance-associated mutations in isolates from children living in endemic areas of Burkina Faso.
Tarama CW; Soré H; Siribié M; Débé S; Kinda R; Ganou A; Nonkani WG; Tiendrebeogo F; Bantango W; Yira K; Sagnon A; Ilboudo S; Hien EY; Guelbéogo MW; Sagnon N; Traoré Y; Ménard D; Gansané A
Malar J; 2023 Jul; 22(1):213. PubMed ID: 37474966
[TBL] [Abstract][Full Text] [Related]
25. The evolution of pyrimethamine resistant dhfr in Plasmodium falciparum of south-eastern Tanzania: comparing selection under SP alone vs SP+artesunate combination.
Malisa AL; Pearce RJ; Mutayoba BM; Abdullah S; Mshinda H; Kachur PS; Bloland P; Roper C
Malar J; 2011 Oct; 10():317. PubMed ID: 22029848
[TBL] [Abstract][Full Text] [Related]
26. High prevalence of pfdhfr-pfdhps triple mutations associated with anti-malarial drugs resistance in Plasmodium falciparum isolates seven years after the adoption of sulfadoxine-pyrimethamine in combination with artesunate as first-line treatment in Iran.
Rouhani M; Zakeri S; Pirahmadi S; Raeisi A; Djadid ND
Infect Genet Evol; 2015 Apr; 31():183-9. PubMed ID: 25653131
[TBL] [Abstract][Full Text] [Related]
27. Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine-pyrimethamine (SP) resistance in eastern Sudan.
Al-Saai S; Kheir A; Abdel-Muhsin AM; Al-Ghazali A; Nwakanma D; Swedberg G; Babiker HA
Infect Genet Evol; 2009 Sep; 9(5):778-83. PubMed ID: 19379843
[TBL] [Abstract][Full Text] [Related]
28. Molecular surveillance of mutations in dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum in Ethiopia.
Gebru-Woldearegai T; Hailu A; Grobusch MP; Kun JF
Am J Trop Med Hyg; 2005 Dec; 73(6):1131-4. PubMed ID: 16354825
[TBL] [Abstract][Full Text] [Related]
29. Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania.
Pearce RJ; Drakeley C; Chandramohan D; Mosha F; Roper C
Antimicrob Agents Chemother; 2003 Apr; 47(4):1347-54. PubMed ID: 12654669
[TBL] [Abstract][Full Text] [Related]
30. High prevalence of sulfadoxine/pyrimethamine resistance alleles in Plasmodium falciparum parasites from Bangladesh.
Marma AS; Mita T; Eto H; Tsukahara T; Sarker S; Endo H
Parasitol Int; 2010 Jun; 59(2):178-82. PubMed ID: 20097306
[TBL] [Abstract][Full Text] [Related]
31. Increasing prevalence of wildtypes in the dihydrofolate reductase gene of Plasmodium falciparum in an area with high levels of sulfadoxine/pyrimethamine resistance after introduction of treated bed nets.
Alifrangis M; Lemnge MM; Rønn AM; Segeja MD; Magesa SM; Khalil IF; Bygbjerg IC
Am J Trop Med Hyg; 2003 Sep; 69(3):238-43. PubMed ID: 14628937
[TBL] [Abstract][Full Text] [Related]
32. Associations of antifolate resistance in vitro and point mutations in dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum.
Biswas S
J Postgrad Med; 2004; 50(1):17-20. PubMed ID: 15047993
[TBL] [Abstract][Full Text] [Related]
33. Sulfadoxine-pyrimethamine efficacy and selection of Plasmodium falciparum DHFR mutations in Burkina Faso before its introduction as intermittent preventive treatment for pregnant women.
Tinto H; Ouédraogo JB; Zongo I; van Overmeir C; van Marck E; Guiguemdé TR; D'Alessandro U
Am J Trop Med Hyg; 2007 Apr; 76(4):608-13. PubMed ID: 17426157
[TBL] [Abstract][Full Text] [Related]
34. DHFR and DHPS genotypes of Plasmodium falciparum isolates from Gabon correlate with in vitro activity of pyrimethamine and cycloguanil, but not with sulfadoxine-pyrimethamine treatment efficacy.
Aubouy A; Jafari S; Huart V; Migot-Nabias F; Mayombo J; Durand R; Bakary M; Le Bras J; Deloron P
J Antimicrob Chemother; 2003 Jul; 52(1):43-9. PubMed ID: 12805261
[TBL] [Abstract][Full Text] [Related]
35. Selection of antifolate-resistant Plasmodium falciparum by sulfadoxine-pyrimethamine treatment and infectivity to Anopheles mosquitoes.
Méndez F; Herrera S; Murrain B; Gutiérrez A; Moreno LA; Manzano M; Muñoz A; Plowe CV
Am J Trop Med Hyg; 2007 Sep; 77(3):438-43. PubMed ID: 17827356
[TBL] [Abstract][Full Text] [Related]
36. Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V.
Oguike MC; Falade CO; Shu E; Enato IG; Watila I; Baba ES; Bruce J; Webster J; Hamade P; Meek S; Chandramohan D; Sutherland CJ; Warhurst D; Roper C
Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):220-229. PubMed ID: 27821281
[TBL] [Abstract][Full Text] [Related]
37. Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania.
Schönfeld M; Barreto Miranda I; Schunk M; Maduhu I; Maboko L; Hoelscher M; Berens-Riha N; Kitua A; Löscher T
Malar J; 2007 Jan; 6():2. PubMed ID: 17224049
[TBL] [Abstract][Full Text] [Related]
38. Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana.
Mockenhaupt FP; Teun Bousema J; Eggelte TA; Schreiber J; Ehrhardt S; Wassilew N; Otchwemah RN; Sauerwein RW; Bienzle U
Trop Med Int Health; 2005 Sep; 10(9):901-8. PubMed ID: 16135198
[TBL] [Abstract][Full Text] [Related]
39. Hitchhiking and selective sweeps of Plasmodium falciparum sulfadoxine and pyrimethamine resistance alleles in a population from central Africa.
McCollum AM; Basco LK; Tahar R; Udhayakumar V; Escalante AA
Antimicrob Agents Chemother; 2008 Nov; 52(11):4089-97. PubMed ID: 18765692
[TBL] [Abstract][Full Text] [Related]
40. Can pretreatment screening for dhps and dhfr point mutations in Plasmodium falciparum infections be used to predict sulfadoxine-pyrimethamine treatment failure?
Omar SA; Adagu IS; Warhurst DC
Trans R Soc Trop Med Hyg; 2001; 95(3):315-9. PubMed ID: 11491006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
